DIAGNOS INC. (DGNOF)
Clinical trial NCT00506870 updates: 1. primary purpose: not set → OTHER 2. collaborators added: Roche Diagnostics GmbH 3. collaborators removed: Hoffmann-La Roche
Clinical trial NCT00506870 updates: 1. primary purpose: not set → OTHER 2. collaborators added: Roche Diagnostics GmbH 3. collaborators removed: Hoffmann-La Roche
📉 **NEGATIVE** • Medium confidence analysis (67%) • Mild negative clinical indicator • Limited downside risk **Sentiment:** Negative (21%) **Content type:** Clinical